advertisement
2.1 Conjunctiva (87)
Showing records 1 to 25
Display all abstracts in classification 2.1 Conjunctiva
Search within classification 2.1 Conjunctiva91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Kobia-Acquah E
Journal of Glaucoma 2021; 30: 180-186
90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Muzychuk A
Journal of Glaucoma 2020; 29: 1162-1172
91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Figus M
Expert Opinion on Drug Delivery 2020; 0: 1-18
91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Ruangvaravate N
Clinical Ophthalmology 2020; 14: 3109-3119
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Giannaccare G
European Journal of Ophthalmology 2020; 0: 1120672120969612
91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Stalmans I
Clinical Ophthalmology 2020; 14: 3675-3680
91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Do A
Ophthalmology. Glaucoma 2021; 4: 343-349
91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Akagi T
Journal of clinical medicine 2020; 9:
91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Kozdon K
PLoS ONE 2020; 15: e0241569
91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Janderová M
?eska a Slovenska Oftalmologie 2021; 77: 28-34
91648 Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Su CC
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1243-1251
91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
So HR
Journal of clinical medicine 2020; 9:
91240 A Case of Primary Open-angle Glaucoma With Conjunctival Laceration After Micropulse Transscleral Cyclophotocoagulation
Kiyama Y
Journal of Glaucoma 2020; 29: e135-e137
91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Caridi B
PLoS ONE 2020; 15: e0241569
91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Okamoto Y
Journal of clinical medicine 2020; 9:
91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Pellegrini M
European Journal of Ophthalmology 2020; 0: 1120672120969612
91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
McGlumphy E
Ophthalmology. Glaucoma 2021; 4: 343-349
91240 A Case of Primary Open-angle Glaucoma With Conjunctival Laceration After Micropulse Transscleral Cyclophotocoagulation
Nakashima KI
Journal of Glaucoma 2020; 29: e135-e137
91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Filouš A
?eska a Slovenska Oftalmologie 2021; 77: 28-34
91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Gyekye GA
Journal of Glaucoma 2021; 30: 180-186
91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Park HYL
Journal of clinical medicine 2020; 9:
91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Choojun K
Clinical Ophthalmology 2020; 14: 3109-3119
91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Lemij H
Clinical Ophthalmology 2020; 14: 3675-3680
91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Agnifili L
Expert Opinion on Drug Delivery 2020; 0: 1-18
90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Racine L
Journal of Glaucoma 2020; 29: 1162-1172